At the start of the year, one of the main causes of the EU’s slow rollout of COVID-19 vaccines was lower than expected supplies from
Read moreBRUSSELS (Reuters) – The European Union drug regulator does not see enough evidence yet to recommend changes to the dosage regime for COVID-19 vaccines, despite
Read moreFILE PHOTO: The logo of Teva Pharmaceutical Industries is seen in Tel Aviv, Israel February 19, 2019. REUTERS/Amir CohenBRUSSELS (Reuters) – Israeli drugmaker Teva is
Read moreWASHINGTON (Reuters) – The Centers for Disease Control and Prevention (CDC) has issued new public health requirements for U.S. visitors who have recently been in
Read moreDUBLIN (Reuters) – Ireland is beginning to see strong early evidence that its COVID-19 vaccine rollout is protecting healthcare workers and care home residents from
Read more(Reuters) – American Grant Holloway said he was not surprised by his blistering pace on the World Indoor Tour circuit this year as he eclipsed
Read more(Reuters) – GlaxoSmithKline and Sanofi on Monday said they had started a new clinical trial of their protein-based COVID-19 vaccine candidate, reviving their efforts against
Read moreJOHANNESBURG (Reuters) – Scientists will meet on Thursday to advise South Africa’s government on its next steps after a study suggested the dominant local coronavirus
Read moreLONDON (Reuters) – Mohamed Noor faces 10 days in COVID-19 quarantine in a hotel room near London’s Heathrow Airport after falling foul of new border
Read more(Reuters) – The number of COVID-19 cases in eastern Europe surpassed 10 million on Friday, according to Reuters tally, as countries across the region aim
Read more